Aptevo Therapeutics (APVO) director converts 400 RSUs into 400 common shares
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. director Grant Grady III exercised 400 Restricted Stock Units (RSUs) into 400 shares of common stock on August 6, 2026. The RSUs convert into common stock on a one-for-one basis. Following the transaction, Grady directly holds 1,150 shares of Aptevo common stock, while the corresponding RSU position was reduced to zero.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 400 shares
Net Buy
2 txns
Insider
Grant Grady III
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 400 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 400 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 1,150 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs Exercised: 400 RSUs
Common Shares Received: 400 shares
Shares Held After Transaction: 1,150 shares
+2 more
5 metrics
RSUs Exercised
400 RSUs
Restricted Stock Units converted into common stock on August 6, 2026
Common Shares Received
400 shares
Shares of Aptevo common stock received upon RSU conversion
Shares Held After Transaction
1,150 shares
Direct common stock holdings of Grant Grady III after the exercise
Par Value
$0.001 per share
Par value of Aptevo common stock into which RSUs convert
Original RSU Grant
7,200 RSUs (400 post-split)
Grant to Grant Grady III on August 6, 2025, vesting after one year
Key Terms
Restricted Stock Unit, derivative security, par value, vest
4 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"transaction_action is described as a derivative exercise/conversion of a derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
par value financial
"common stock, $0.001 par value per share, of the Issuer"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
vest financial
"RSUs, vesting on the first anniversary of the date of grant"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Aptevo Therapeutics (APVO) director Grant Grady III report in this Form 4?
Grant Grady III reported exercising 400 RSUs into 400 shares of Aptevo common stock on August 6, 2026. This was recorded as an exercise or conversion of a derivative security into common stock.
What type of securities did the RSUs convert into for Aptevo Therapeutics (APVO)?
The RSUs converted into common stock of Aptevo Therapeutics, with a stated $0.001 par value per share. The conversion occurred on a one-for-one basis between each RSU and one share of common stock.
How many Restricted Stock Units did Grant Grady III exercise in Aptevo Therapeutics (APVO)?
Grant Grady III exercised 400 Restricted Stock Units, which converted into 400 shares of common stock. The Form 4 identifies this as an exercise or conversion of a derivative security with no remaining units from this block.
When were the Aptevo Therapeutics (APVO) RSUs originally granted to Grant Grady III?
The RSUs were originally granted on August 6, 2025, in an amount of 7,200 RSUs (400 post-split). According to the footnote, they were scheduled to vest on the first anniversary of the grant date.